Categories: NewsPharmaceutical

Model N Management to Present at the Raymond James 2023 TMT and Consumer Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SAN MATEO, Calif.–(BUSINESS WIRE)–Model N, Inc. (NYSE: MODN), the leader in revenue optimization and compliance today announced that Model N management will present at the Raymond James 2023 TMT and Consumer Conference. On December 5, 2023 at 5:35 a.m. PT (8:35 a.m. ET).

A webcast of the live and replay presentation will be accessible from the investor relations page of the Model N website at https://investor.modeln.com/.

About Model N

Model N is the leader in revenue optimization and compliance for pharmaceutical, medtech and high-tech innovators. Our intelligent platform powers your digital transformation with integrated technology, data, analytics, and expert services that deliver deep insight and control.

Our integrated cloud solution is proven to automate pricing, incentive and contract decisions to scale business profitably and grow revenue. Model N is trusted across more than 120 countries by the world’s leading pharmaceutical, medical technology, semiconductor, and high-tech companies, including Johnson & Johnson, AstraZeneca, Stryker, Seagate Technology, Broadcom, and Microchip Technology. For more information, visit www.modeln.com.

Contacts

Investor Relations Contact:

Carolyn Bass

investorrelations@modeln.com

Public Relations

BLASTmedia

modeln@blastmedia.com

Staff

Recent Posts

Thought Technology Ltd. Continues Its Tradition of Supporting the AAPB Conference with World-Class Biofeedback Solutions and a Poker-Themed Exhibitor Demo

MONTREAL, May 6, 2025 /PRNewswire/ -- Thought Technology Ltd., a global leader in biofeedback instrumentation,…

3 hours ago

Mars Puts Pet Health in Pet Parents’ Hands with new Artificial Intelligence Powered Tools

Mars introduces a global portfolio of artificial intelligence (AI) powered digital health tools to help…

3 hours ago

Astraveus Enters Strategic Partnership with NecstGen to evaluate Lakhesys Benchtop Cell Factory™ for CAR-T therapy manufacturing

Agreement with Netherlands Center for the Clinical Advancement of Stem Cell and Gene Therapies (NecstGen)…

3 hours ago

Compliancy Group’s New Pricing and Packaging Delivers More Flexibility and Affordability for Healthcare Compliance

NEW YORK, May 6, 2025 /PRNewswire/ -- Compliancy Group, the leading provider of healthcare compliance…

3 hours ago